Navigation Links
Regulators Object Drug Produced from Genetically Engineered Farm Animals

European regulators have not given the green signal to a drug produced in the milk of genetically engineered farm animals// . This is a step retrograde to a budding industry that sought to enable low cost pharmaceutical options from farm animals

GTC Biotherapeutics, proponents of this drug, have decided to appeal the decision, expressing their opinion that the verdict came about only on the basis of a problem in the clinical trial, and certainly not from the fact that the drug was produced in the goats.

With a new technology there is a conservatism that is not inappropriate, Geoffrey Cox, chief executive of GTC, said during a conference call with analysts. But he added, There is no way with this company and what we have achieved over 15 years that we will let this block us from getting the product to market.

Companies like the GTC inject human genes into the animals that cause them to produce a human protein in their milk. The animal’s milk can then be used to extract the protein which can later be purified and used as a drug.

This method is cost effective and less cumbersome to produce such types of biotechnology drugs. Cancer-fighting monoclonal antibodies and many such drugs are produced using cultures of genetically engineered animal cells. These factories are a very expensive proposition costing several hundred million dollars for each factory.

Many other protein drugs, similar to the one developed by GTC, are done after the protein is extracted from donated blood. But these quantities in donated blood are found in very minimal quantities and run short to meet the actual demand. According to GTC, almost 90,000 blood donations would be required to produce the amount of protein the goats can produce in just one year.

Drug companies have been reticent to try this technology, mainly because of the wariness portrayed by drug regulators. GTC now proposes to seek the approval on its own steam to take its efforts in biotechnology forward.
'"/>




Related medicine news :

1. A brush with the U.S. Regulators can cost a fortune
2. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
3. Australian Drug Regulators Call for Revamp On The Pharmaceutical Surveillance
4. Drug Regulators Need To Think In Long-Term, Say Charities
5. European Regulators Investigate Common Painkiller Drugs
6. Canadian Regulators allow Silicone Breast Implants in Market
7. New Study Challenges How Regulators Determine Risk
8. Researchers Urge Regulators to Rethink Strategies for Soot Emission
9. Local Community Objects to Mental Facility
10. Doctors Object To Elective Surgery Cuts In New South Wales
11. Healthy People 2010 Objectives Aims To Reduce Oral Health Disparities In Society
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... 24, 2017 , ... The law firm of Enea, Scanlan & Sirignano, ... Westchester resident Lauren C. Enea has joined the firm as an associate attorney. Ms. ... practice in elder law, Medicaid planning and applications, and Wills, Trusts and Estates. ...
(Date:3/24/2017)... Miami, FL (PRWEB) , ... March 24, 2017 ... ... HyGIeaCare Inc. ( http://www.hygieacare.com ) announced their partnership to prep patients for colonoscopy ... Health Endoscopy Centers in 87th Ave., Miami, FL. , The ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... Medical Reiki™ Master in Frederick, MD. Judy says, “I am passionate about sharing ... is often a very difficult and challenging time.” , A Certified Medical Reiki™ ...
(Date:3/24/2017)... ... 24, 2017 , ... “End Time GPS”: a dauntless and enlightened study ... Time GPS” is the creation of published author, Wesley Gerboth, a World War II ... and space-vehicle projects. Now, at age ninety-one, he shares the Wisdom God bestowed upon ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Communion of Saints: A ... God in congregations across the United States. “The Communion of Saints” is ... who has served congregations in seven states throughout his long career of devotion ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... 2035" report to their offering. ... The Deep Learning: Drug Discovery and Diagnostics Market, ... growing market of deep learning solutions within the healthcare domain. Primarily ... as a novel solution to generate relevant insights from medical data. ...
(Date:3/24/2017)...  GenomeDx Biosciences today announced that six abstracts featuring ... Cancer Classifier tests will be presented at the 32 ... held March 24 to 28, 2017 in ... Europe,s largest urological event showcasing ... field. The abstract titled "Muscle invasive bladder ...
(Date:3/24/2017)... and GENEVA , March 24, 2017 ... Tuberculosis Day revitalizes efforts to develop sutezolid as effective ... World Tuberculosis Day, TB Alliance and the Medicines Patent ... development of sutezolid, an antibiotic drug candidate which demonstrated ... the development of sutezolid in combination with other TB ...
Breaking Medicine Technology: